Sage Journals: Discover world-class research

Retricted access

Research article

First published 1998-11

Comparative Study of the Pharmacodynamic and Pharmacologic Effects of Betaseron ® and AVONEX ™

Gary J. Williams, Patricia L. Witt

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 2006-06

Interferon beta-1b (Betaseron®/Betaferon®) is well tolerated at a dose of 500 mg: interferon dose escalation assessment of safety (IDEAS)

M H Gottesman, S Friedman-Urevich

Multiple Sclerosis Journal

Retricted access

Research article

First published 1996-12

A therapeutic and economic assessment of betaseron® in MS

M G Brown, T J Murray, J D Fisk [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2001-12

A prospective,open-label treatment trial to compare the effect of IFNβ-1a (Avonex®),IFNβ-1b (Betaseron®),and glatiramer acetate (Copaxone®) on the relapse rate in relapsing-remitting multiple sclerosis: results after 18 months of therapy

Omar A Khan, Alexandros C Tselis, John A Kamholz [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2007-5

Clinical relevance of anti-drug antibodies with interferon beta-1b therapy in multiple sclerosis

M. Cantillon, I. Antonijevic

Multiple Sclerosis Journal

Retricted access

Brief report

First published 2002-12

Short Communication: A Comparison of the Biologic Activity of Two Recombinant IFN- β Preparations Used in the Treatment of Relapsing-Remitting Multiple Sclerosis

Francesco Antonetti, Ornella Finocchiaro, Michele Mascia [...]

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 1998-12

A Novel Bioassay for the Determination of Neutralizing Antibodies to IFNβ1b

Erno Pungor, James G. Files, Jeffrey D. Gabe [...]

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 2011-03

Frequency and Magnitude of Interferon β Neutralizing Antibodies in the Evaluation of Interferon β Immunogenicity in Patients with Multiple Sclerosis

Sidney E. Grossberg, Joel Oger, Leslie D. Grossberg [...]

Journal of Interferon & Cytokine Research

Retricted access

Review article

First published 2010-10

PEGylated Interferon Beta-1a: Meeting an Unmet Medical Need in the Treatment of Relapsing Multiple Sclerosis

Darren P. Baker, Robert Blake Pepinsky, Margot Brickelmaier [...]

Journal of Interferon & Cytokine Research

Retricted access

Other

First published 2007-11

Reduced effectiveness of long-term interferon-β treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study

C. Boz, J. Oger, E. Gibbs [...]

Multiple Sclerosis Journal

Search results